International Clinical Trial: A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07198035) titled 'A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144' on Sept. 25.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Pfizer

Condition: Healthy Adults

Intervention: Drug: PF-07248144

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: September 18, 2025

Target Sample Size: 12

Countries of Recruitment: Belgium

To know more, visit https://clinicaltrials.gov...